|
Unomedical hereby submits this initial report as part of its complaint remediation activities conducted under a capa 2356421 and capa 2566479 in accordance with the fda action plan, which incorporates (b)(4)(ic retrospective complaint review) and (b)(4) (ic retrospective mdr review).This submission includes a retrospective reassessment of previously evaluated complaints.Unomedical is providing this supplemental information in accordance with the reporting requirements set forth in 21 cfr part 803.Any fields left blank indicate that the information is unknown, unavailable, or remains unchanged
validation error was observed for the outcome "required intervention to prevent permanent impairment/damage (devices)." the outcome was removed from the outcomes attributed to ae tab; however, the outcome remains documented within the complaint information.The case was updated and resubmitted
based on the available information, this event is deemed to be a serious injury
request was performed for additional information including lot number; however, lot number was not provided.A complaint investigation was initiated under complaint investigation.Unfortunately, no specific lot number was identified, which limits the ability to trace or analyze a particular item.Investigation in progress.To date no additional information has been received.Should additional information become available, a follow-up report will be submitted.Fda registration number
reporting site: 8021545,
manufacturing site: 3003442380.
|